|Bid||281.56 x 900|
|Ask||281.96 x 1000|
|Day's range||267.03 - 292.33|
|52-week range||54.10 - 292.33|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||51.59|
|Earnings date||09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||200.87|
Dr. Shikha Jain, Assistant Professor of Medicine, University of Illinois Chicago, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Dr. Heather Yeo, SurvivorNet Medical Advisor & Associate Professor of Surgery and Healthcare Policy and Research at Weill Cornell Medical College, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Higher sales of Pfizer's (PFE) key brands, Eliquis, Xeljanz, and Inlyta, and revenues from COVID-19 vaccine are likely to have driven sales in the second quarter.